Equities

ViroGates A/S

VIRO:CPH

ViroGates A/S

Actions
  • Price (DKK)5.80
  • Today's Change0.150 / 2.65%
  • Shares traded268.00
  • 1 Year change-62.39%
  • Beta0.8619
Data delayed at least 15 minutes, as of Sep 20 2024 16:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of DKK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments169.8815
Total Receivables, Net3.133.623.24
Total Inventory5.143.771.70
Prepaid expenses0.090.040.04
Other current assets, total--0.00--
Total current assets241720
Property, plant & equipment, net00.040.22
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term0.180.190.18
Other long term assets0.00--0.00
Total assets251820
LIABILITIES
Accounts payable1.560.570.38
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total0.690.883.42
Total current liabilities2.251.453.80
Total long term debt5.3000
Total debt5.3000
Deferred income tax------
Minority interest------
Other liabilities, total------
Total liabilities7.551.453.80
SHAREHOLDERS EQUITY
Common stock--3.353.17
Additional paid-in capital------
Retained earnings (accumulated deficit)--1313
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total17----
Total equity171616
Total liabilities & shareholders' equity251820
Total common shares outstanding6.444.344.11
Treasury shares - common primary issue0.000.000.00
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.